Ultiva

Remifentanil Hydrochloride

6.9 High risk

Ultiva & Anaphylactic shock

64.9%

of users reported Anaphylactic shock

45.9%

also reported Life-threatening condition

55.6%

are men

Most common medical consequences

Life-threatening condition

45.9%

Hospitalization

32.4%

Severe reaction

18.9%

Death

2.7%

Have you experienced any negative side effects from this medication?

Ultiva: general information

Most common side effects (3)

Most commonly affected ages

60 - 69 years

45.8%

70 - 79 years

<0.1%

80 - 89 years

54.2%

On this page